Global Rank
#29854
Country Rank
n/a
Market Cap
47.22 M
Price
8.54
Change (%)
0.62%
Volume
3,206
Captor Therapeutics Spolka Akcyjna's latest marketcap:
47.22 M
As of 06/07/2025, Captor Therapeutics Spolka Akcyjna's market capitalization has reached $47.22 M. According to our data, Captor Therapeutics Spolka Akcyjna is the 29854th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 47.22 M |
| Revenue (ttm) | 5.12 M |
| Net Income (ttm) | -10,882,234.88 |
| Shares Out | 5.53 M |
| EPS (ttm) | -2.18 |
| Forward PE | 49.69 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/28/2025 |
Market Cap Chart
Data Updated: 06/07/2025
Captor Therapeutics Spolka Akcyjna's yearly market capitalization.
Captor Therapeutics Spolka Akcyjna has seen its market value drop from zł742.21 M to zł178.58 M since 2021, representing a total decrease of 75.94% and an annual compound decline rate (CAGR) of 33.94%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | zł178.58 M | -9.74% |
| 12/30/2024 | zł197.24 M | -57.12% |
| 12/29/2023 | zł459.93 M | -31.04% |
| 12/30/2022 | zł666.9 M | -10.15% |
| 12/30/2021 | zł742.21 M |
Company Profile
About Captor Therapeutics Spolka Akcyjna
Captor Therapeutics Spolka Akcyjna is a biopharmaceutical company specializing in the discovery and development of innovative protein degradation drugs. Their primary focus areas include treatments for cancer and autoimmune diseases.
Key Highlights
- Targeted Protein Degradation Technology: Overcomes limitations of traditional drugs by effectively removing disease-causing proteins resistant to current therapies.
- Preclinical Pipeline: Features multiple therapeutic molecules in development, targeting high-need medical conditions.
- Founded: 2015
- Headquarters: Wroclaw, Poland
Frequently Asked Questions
-
What is Captor Therapeutics Spolka Akcyjna's (WSE-CTX) current market cap?As of 06/07/2025, Captor Therapeutics Spolka Akcyjna (including the parent company, if applicable) has an estimated market capitalization of $47.22 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Captor Therapeutics Spolka Akcyjna (WSE-CTX) rank globally by market cap?Captor Therapeutics Spolka Akcyjna global market capitalization ranking is approximately 29854 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.